But EGFR-resistance and downstream signaling gene STAT3 activation contributes to cell proliferation, anti-apoptosis, and resistance to CD8+ T cells in EGFR-positive lung cancer [19,20]. This evidence concerns the gene STAT3 and lung cancer.